Visual impairment and cognitive decline: understanding the longitudinal relationships and mechanisms
视觉障碍和认知能力下降:理解纵向关系和机制
基本信息
- 批准号:10572333
- 负责人:
- 金额:$ 13.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdultAffectAgingAlzheimer associated neurodegenerationAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAreaBlood VesselsBrainCerebrovascular DisordersCharacteristicsChronicClinicalClinical assessmentsCognitionCognitiveCommunitiesComplementComplexContrast SensitivityDataData SourcesDementiaDevelopmentDiseaseElderlyEpidemiologyEquationEtiologyEye diseasesFosteringFutureGeneticGenotypeGoalsHealthImpaired cognitionK-Series Research Career ProgramsLifeLinkMeasuresMediatingMental DepressionMentorshipMicrovascular DysfunctionModelingNerve DegenerationOutcomePathway interactionsPatternPlayProcessPsychological FactorsQuality of lifeResearchResearch PersonnelRiskRisk FactorsRoleScientistSocial isolationStatistical MethodsStatistical ModelsStructureTechniquesThickTrainingTraining ActivityVisionVision DisordersVisual AcuityVisual impairmentWhite Matter Hyperintensitybiobankbrain magnetic resonance imagingcardiovascular disorder riskcognitive functioncognitive neurosciencecognitive reservecohortepidemiology studyexperienceimprovedmiddle agemodifiable riskneuroimagingnormal agingnovelpreservationpreventprogramspsychologicsexskillssocialsocial engagementstatistics
项目摘要
PROJECT SUMMARY/ABSTRACT
Visual impairment (VI) and cognitive impairment are chronic conditions that disproportionately affect older
adults. Research has revealed a consistent relationship between VI and cognitive impairment and dementia in
older adults. VI is a risk factor for Alzheimer disease (AD) and is associated with future cognitive decline.
However, the extent to which VI is associated with the characteristics of the longitudinal cognitive trajectory of
aging adult remains unclear, particularly how VI status in midlife affects the cognitive trajectory in older life.
Additionally, the mechanisms through which VI affects cognitive functioning have not been well elucidated. VI
and cognitive decline could both be the result of a common underlying cause such as brain neurodegeneration.
Alternatively, VI may reduce older adults’ ability to participate in activities and engage socially, which become
risk factors for cognitive decline. Cardiovascular diseases (CVD) risk factors influence the risk of both VI and
cognitive outcomes which may serve as important etiologic pathways underlying cognitive impairment.
Important genetic factors such as APOE ε4 which is positively associated with AD has been demonstrated to
be related to certain cerebrovascular diseases and visual disorders. These important and complex
associations among VI, CVD risk factors, brain neurodegeneration, APOE ε4 genotype and cognitive decline
have not been studied in a systematic and comprehensive manner. The current proposal leverages two large
epidemiological cohort (The Health ABC Study and UK Biobank) and presents an unprecedented opportunity
to employ sophisticated and novel application of Structure Equation Modeling techniques to investigate the
complex associations between VI, brain neurodegeneration, CVD risk factors, APOE ε4 genotype, and
sociopsychological factors as they relate to the longitudinal trajectories of cognitive decline and the linking
mechanisms between VI and cognitive decline. The research in this career development award is
complemented by training activities that build on the candidate’s strong background in statistics and provides
new trainings on 1) cognitive neurosciences and clinical assessment of normal aging, cognitive impairment and
AD; 2) cerebrovascular disease and risk factors and their relevant disease mechanisms and consequences; 3)
neuroimaging and markers of brain neurodegeneration; 4) clinical aspects of VI and conducting ocular
epidemiological study. This sophisticated research and training plan combined with a highly experienced and
committed mentorship team will facilitate acquisition of meaningful skills and foster the applicant’s development
into an independent investigator. This research will answer the important question of whether VI is associated
with accelerated downward trajectories of cognitive decline and will elucidate critical underlying mechanisms
linking VI with cognitive decline. The treatment for AD and ADRD is currently very limited. VI is a prevalent
condition that is highly treatable and represents an important modifiable risk factor that can be prevented and
treated as an effective means to preserve cognitive function and improve quality of life.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dandan Diane Zheng其他文献
Dandan Diane Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dandan Diane Zheng', 18)}}的其他基金
Health Disparities in Visually Impaired Adults with Multimorbidity
患有多种疾病的视障成人的健康差异
- 批准号:
9117135 - 财政年份:2016
- 资助金额:
$ 13.26万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 13.26万 - 项目类别:
Research Grant














{{item.name}}会员




